Orexigen Therapeutics (OREX)
Orexigen Therapeutics News
Vivus' Qnexa Is Not Guaranteed Approval. Remember Provenge?
Benzinga about 3 hours ago2012's 2 Best Health-Care Stocks
Fool about 2 days ago3 Health-Care Stocks Crushing the Market
about 3 days agoArena is Hands Down a Better Investment than Vivus
Fool about 4 days agoArena is Hands Down a Better Investment than Vivus
4 Smaller Alternatives to Big Pharma Obesity Treatments
Benzinga about 6 days agoFDA Approval Sends this Biopharma Company Soaring 74%
about 16 days agoVIVUS Is A Viable Long Term Investment
about 17 days agoOrexigen Therapeutics To Be Added to the NASDAQ Biotechnology Index
Benzinga about 17 days agoOrexigen® Therapeutics To Be Added to the NASDAQ Biotechnology Index
PR Newswire about 17 days agoSAN DIEGO, May 14, 2012 /PRNewswire/ -- Orexigen Therapeutics, Inc. (OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that it will be added to the NASDAQ ...
Mulling Arena Pharma's Future With Obesity Drug on Approval Path
about 17 days ago[$$] Here's the Skinny on Arena
about 17 days agoWhy This Biotech Crushed the Market
about 17 days agoArena and Orexigen Compete to Bring First Weight Loss Drug to Market in Nearly 13 Years
Marketwire about 17 days agoNEW YORK, NY-- - Biotech companies are looking to cash in on the anti-obesity drug market. The race to bring the first weight-loss pill to the market is heating up as Arena Pharmaceuticals weight-loss ...
You may also be interested in these OREX related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| OREX | 3.35 | -0.07 | -2.05% | 231.67M |
| SWX | 41.98 | +0.24 | +0.57% | 1.924B |
| SWU | 117.64 | +0.51 | +0.44% | |
| SWS | 5.70 | -0.06 | -1.04% | 187.83M |
| SWN | 28.07 | -0.07 | -0.25% | 9.822B |
| SWM | 66.80 | +0.15 | +0.23% | 1.062B |
| SRLS | 4.01 | +0.00 | +0.00% | 80.64M |
| SRI | 7.06 | +0.11 | +1.58% | 195.50M |
| SREV | 11.99 | -0.05 | -0.42% | 891.92M |
| SRE | 65.10 | +0.55 | +0.85% | 15.54B |
